bioRxiv Science⌕ Search

Biology subjects

Ben-Yosef, D.

Publications and source records attributed to Ben-Yosef, D..

4 recordsLinked to original sources

Clocks and Dominoes: Timing Mechanisms of Embryogenesis

How developmental timings are regulated is a fundamental open question. Two widely considered mechanisms are the clock, in which an internal timer determines when each stage occurs, and the domino, in which the completion of each stage triggers the next. It is often unclear how to establish either mechanism. Here, we construct a quantitative framework that uses the correlation structure of developmental timings to test the clock and domino mechanisms. We apply this framework to human pre-implantation development by using ~1 million images of 2946 embryos acquired during IVF treatment, establishing mathematical models of developmental rate. We find that a domino mechanism governs the cleavage timings, while a pronuclei fade-triggered clock mechanism governs the morula and blastocyst timings. These results are consistent with the cell cycle oscillator governing the cleavage timings and the accumulation of embryonic gene products or the degradation of maternally deposited factors governing the morula and blastocyst timings. We next investigate the physiological regulators of developmental timing by analyzing how the timings are statistically associated with the clinical pregnancy outcome. While embryos that result in a clinical pregnancy tend to exhibit shorter cleavage timings, this association is primarily driven by patient-specific properties. In contrast, embryo-specific properties independently influence the pregnancy outcome and the cleavage timings, so that factors directly determining implantation potential, such as aneuploidy, can only weakly impact the cleavage timings. Taken together, this work provides a robust framework for decoding developmental timing mechanisms, with significant implications for fundamental biology and clinical practice.

developmental biology↗

In-depth characterization of apoptosis N-terminome reveals a link between caspase-3 cleavage and post-translational N-terminal acetylation

The N-termini of proteins contain information about their biochemical properties and functions. These N-termini can be processed by proteases and can undergo other co- or post-translational modifications. We have developed LATE (LysN Amino Terminal Enrichment), a method that uses selective chemical derivatization of -amines to isolate the N-terminal peptides, in order to improve N-terminome identification in conjunction with other enrichment strategies. We applied LATE alongside another N-terminomic method to study caspase-3 mediated proteolysis both in vitro and during apoptosis in cells. This has enabled us to identify many unreported caspase-3 cleavages, some of which cannot be identified by other methods. Moreover, we have found direct evidence that neo-N-termini generated by caspase-3 cleavage can be further modified by Nt-acetylation. Some of these neo-Nt-acetylation events occur in the early phase of the apoptotic process and may have a role in translation inhibition. This has provided a comprehensive overview of the caspase-3 degradome and has uncovered previously unrecognized crosstalk between post-translational Nt-acetylation and caspase proteolytic pathways.

biochemistry↗

Tripartite Inhibition of SRC-WNT-PKC Signalling Consolidates Human Naive Pluripotency

Different conditions have been devised to isolate MEK/ERK signalling independent human naive pluripotent stem cells (PSCs) that are distinct from conventional primed PSCs and better correspond to pre-implantation developmental stages. While the naive conditions described thus far endow human PSCs with different extents of naivety features, isolating human pluripotent cells that retain characteristics of ground state pluripotency while maintaining differentiation potential and genetic integrity, remains a major challenge. Here we engineer reporter systems that allow functional screening for conditions that can endow both the molecular and functional features expected from human naive pluripotency. We establish that simultaneous inhibition of SRC-NF{kappa}B, WNT/{beta}CATENIN and PKC signalling pathways is essential for enabling expansion of teratoma competent fully naive human PSCs in defined or xeno-free conditions. Divergent signalling and transcriptional requirements for maintaining naive pluripotency were found between mouse and human. Finally, we establish alternative naive conditions in which MEK/ERK inhibition is substituted with inhibition for NOTCH/RBPj signalling, which allow obtaining alternative human naive PSCs with diminished risk for loss of imprinting and deleterious global DNA hypomethylation. Our findings set a framework for the signalling foundations of human naive pluripotency and may advance its utilization in future translational applications. Highlights of key findingsO_LICombined inhibition of SRC, WNT and PKC signaling consolidates human naive pluripotency C_LIO_LIStable expansion of DNA/RNA methylation-independent and TGF/ACTIVIN-independent human naive PSCs C_LIO_LIOpposing roles for ACTIVIN and WNT/{beta}CATENIN signaling on mouse vs. human naive pluripotency C_LIO_LI2i and MEK/ERKi independent alternative human naive PSC conditions via inhibiting NOTCH/RBPj signaling C_LI

developmental biology↗

Neural differentiation is increased by GSK-3β inhibition and decreased by tankyrase inhibition in human neural precursor cells

Glycogen synthase kinase-3{beta} (GSK-3{beta}) and tankyrase-1/2 (TANK) are two enzymes known to play multiple roles in cell biology, including regulation of proliferation, differentiation and metabolism. Both of them act on the canonical Wnt/{beta}-Catenin pathway, but are also involved in many other independent intracellular mechanisms. More importantly, GSK-3{beta} and TANK have been shown to play crucial roles in different diseases, including cancer and neurological disorders. The GSK-3{beta}-inhibitor CHIR and the TANK-inhibitor XAV are two pyrimidine molecules, holding high potential as possible therapeutic drugs. However, their effect on neural tissue is poorly understood. In this study, we tested the effects of CHIR and XAV on human neural precursor cells (hNPCs) derived from human embryonic stem cells. We found that CHIR-mediated inhibition of GSK-3{beta} promotes neural differentiation. In contrast, XAV-mediated inhibition of TANK leads to de-differentiation. These results highlight the relative importance of these two enzymes in determining the neurodevelopmental status of hNPCs. Furthermore, they shed light on the roles of Wnt signaling during early human neurogenesis.

cell biology↗